Novo Nordisk's Diabetes Drug Outshines Ozempic: Buy?
A new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
Learn various ways to earn money through gig work. Explore strategies to enhance your income through flexible opportunities.
24,561 articlesA new diabetes drug from Novo Nordisk could change the GLP-1 landscape. This deep dive breaks down what investors sho...
A pivotal Nvidia partner just joined the Nasdaq, delivering triple-digit growth with demand for memory and AI workloa...
In February 2026, top performing alcohol stocks outperformed broader markets as premium brands drive margins and growth.
When choosing biotech ETFs, investors face a trade-off between concentration and breadth. This article compares FBT a...
January data show a pending home sales fall, signaling continued headwinds for buyers even as rates move modestly low...
As year-to-date markets swing, Disney and PayPal stand out as potential rebound plays. This article weighs dividends,...
Ultra-prime Manhattan sales are accelerating even as policy debates intensify. Brokers say buyers and sellers remain ...
Three giants of U.S. banking posted strong Q1 results, yet each faces a different market reality. JPMorgan sits near ...
As Pool Corp closes its Q4, investors weigh the implications for pool corp (pool) 2025. This guide breaks down the ea...
A hypothetical AI model using ChatGPT analyzes SpaceX as a public company in a volatile market, forecasting a potenti...
Rumors around chip supply and product timelines can move markets quickly. This guide shows how AMD typically responds...
June's consumer price index fell 0.4% month over month, with core prices flat. Gasoline relief helped lower the headl...